Venrock Healthcare Capital Partners III and affiliates report acquiring $37.65 million in Lycia Therapeutics shares
LYCA•Venrock-affiliated funds reported beneficial ownership of 6,825,233 Lycia Therapeutics common shares. The reported holdings included 1,944,444 shares purchased at $18 each and 4,779,793 shares added through preferred-stock conversions.
1. Reported holdings
Venrock-affiliated funds reported beneficial ownership of 6,825,233 Lycia Therapeutics common shares. The holdings included 1,944,444 common shares purchased at $18 per share and 4,779,793 common shares from conversion of Series C and Series D Preferred Stock. Bong Y. Koh and Nimish P. Shah were listed as reporting 10% owners.
